title: Predictive value of age-related acute insulin response to glucose in subjects at risk for type 1 diabetes: results of a 6-year follow-up study from west-France.
abstract: The acute insulin response to i.v. glucose (AIRG) was evaluated in 344 first-degree relatives of patients with Type 1 diabetes. In 318 relatives aged 3 to 48 years without islet cell antibody and insulin autoantibody, correlations (p < 0.0006) were found between age and fasting insulinaemia, fasting glycaemia, or AIRG, with a peak during puberty. Assuming that these relatives without islet cells and insulin auto-antibodies have a low risk of developing Type 1 diabetes, we provided a "standard age-related chart" for AIRG with a "low" AIRG defined as a value below the 1st percentile for each pubertal stage. Using these cut-off points, predictive characteristics of a low AIRG for progression towards diabetes within 6 years were analysed. Four relatives developed diabetes and one displayed impaired oral glucose tolerance. Four out of these 5 subjects had islet cell and insulin auto-antibodies, but the other one was negative for these markers. Three of these 5 subjects had low AIRG at entry (30, 24 and 1 months before diabetes, respectively). The two others displayed a steady progressive decline (p < 0.02) of age-related during the follow-up before impaired oral glucose tolerance and diabetes appeared (rate of decline: 15 microU/ml/year). Thus, independently of the presence of islet cell antibodies, the predictive value of a low age-related AIRG during the follow-up is greater than the single low AIRG at entry.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Clinique d'Endocrinologie et Laboratoire d'Immunologie du Diabète, Nantes, France.
authors.forename: S
authors.initials: S
authors.lastname: Bardet
authors.forename: M G
authors.initials: MG
authors.lastname: Joseph
authors.forename: D
authors.initials: D
authors.lastname: Maugendre
authors.forename: E
authors.initials: E
authors.lastname: Matthieu
authors.forename: L
authors.initials: L
authors.lastname: Chaillous
authors.forename: G
authors.initials: G
authors.lastname: Semana
authors.forename: J M
authors.initials: JM
authors.lastname: Limal
authors.forename: H
authors.initials: H
authors.lastname: Allannic
authors.forename: B
authors.initials: B
authors.lastname: Charbonnel
authors.forename: P
authors.initials: P
authors.lastname: Sai
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D005602:France; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D011236:Prediabetic State / Q000175:diagnosis* / Q000235:genetics; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D007328:Insulin; D005947:Glucose